AKT1 and adenomyosis: Therefore, one therapeutic strategy for intervening in the development and progression of adenomyosis involves inhibiting the excessive activation of the PI3K/AKT/mTOR signaling pathway, thereby regulating the balance between proliferation and apoptosis.